Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-INDAPAMIDE MYLAN PHARMACEUTICALS ULC Actual shortage 1.25MG Updated Report 2025-11-19 271405
LUPIN-PROPRANOLOL LA LUPIN PHARMA CANADA LIMITED Actual shortage 80MG Updated Report 2025-11-19 272143
EUGIA-ONDANSETRON INJECTION EUGIA PHARMA INC. Actual shortage 2MG Updated Report 2025-11-18 257697
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION EUGIA PHARMA INC. Actual shortage 100MCG Updated Report 2025-11-18 262460
ACYCLOVIR SODIUM INJECTION EUGIA PHARMA INC. Actual shortage 50MG Updated Report 2025-11-18 270922
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Actual shortage 20MG Updated Report 2025-11-18 271316
FLUDARABINE PHOSPHATE INJECTION, USP ACCORD HEALTHCARE INC Resolved 25MG Updated Report 2025-11-18 247144
DEXTROSE INJECTION USP PFIZER CANADA ULC Resolved 500MG Updated Report 2025-11-18 190311
DEXTROSE INJECTION USP PFIZER CANADA ULC Resolved 500MG Updated Report 2025-11-18 192972
DEXTROSE INJECTION USP PFIZER CANADA ULC Resolved 500MG Updated Report 2025-11-18 200792

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
VIRAZOLE BAUSCH HEALTH, CANADA INC. To be discontinued 6G New Report 2025-11-18 272123
SANDOZ GEFITINIB SANDOZ CANADA INCORPORATED Discontinued 250MG New Report 2025-11-18 272120
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2025-11-18 257374
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 10MG Updated Report 2025-11-18 257368
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 25MG Updated Report 2025-11-18 257377
TARO-LANSOPRAZOLE SUN PHARMA CANADA INC To be discontinued 30MG Updated Report 2025-11-17 272029
TARO-LANSOPRAZOLE SUN PHARMA CANADA INC To be discontinued 15MG New Report 2025-11-17 272026
CLINDOXYL GEL GLAXOSMITHKLINE INC Discontinued 5% 1% Updated Report 2025-11-14 270515
GLUCOPHAGE SANOFI-AVENTIS CANADA INC To be discontinued 850MG New Report 2025-11-14 271873
ARAVA SANOFI-AVENTIS CANADA INC To be discontinued 10MG New Report 2025-11-14 271870